The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFR-Inhibitors: Did We Really Find the Target? Article

Passiglia, Francesco, Van der Steen, Nele, Raez, Luis et al. (2014). The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFR-Inhibitors: Did We Really Find the Target? . CURRENT DRUG TARGETS, 15(14), 1284-1292. 10.2174/138945011514141216092739

International Collaboration

cited authors

  • Passiglia, Francesco; Van der Steen, Nele; Raez, Luis; Pauwels, Patrick; Gil-Bazo, Ignacio; Santos, Edgardo; Santini, Daniele; Tesoriere, Giovanni; Russo, Antonio; Bronte, Giuseppe; Zwaenepoel, Karen; Cappuzzo, Federico; Rolfo, Christian

sustainable development goals

authors

publication date

  • January 1, 2014

published in

keywords

  • 1ST-LINE TREATMENT
  • ANAPLASTIC LYMPHOMA
  • C-MET RECEPTOR
  • EGFR-TKIs resistance
  • FACTOR-SCATTER FACTOR
  • GENE COPY NUMBER
  • GROWTH-FACTOR
  • HEPATOCYTE GROWTH
  • HGF
  • Life Sciences & Biomedicine
  • NSCLC
  • OPEN-LABEL
  • Pharmacology & Pharmacy
  • RANDOMIZED PHASE-II
  • RECEPTOR TYROSINE KINASE
  • Science & Technology
  • cMET
  • cMET-Inhibitors
  • targeted therapies

Digital Object Identifier (DOI)

publisher

  • BENTHAM SCIENCE PUBL LTD

start page

  • 1284

end page

  • 1292

volume

  • 15

issue

  • 14